RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Lonp1 expression and correlation with mitophagy and immune infiltration markers in colon adenocarcinoma.
Lonp1 expression and correlation with mitophagy and immune infiltration markers in colon adenocarcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
LONP1 是一种线粒体 ATP 依赖性蛋白酶,通过调控蛋白质周转和线粒体自噬在线粒体稳态中发挥关键作用。近期研究强调其在多种癌症中表达上调,包括结直肠癌(CRC)。
本研究探讨 LONP1 在结肠腺癌(COAD)中的表达及其与线粒体自噬相关蛋白和免疫浸润标志物的相关性。利用公共数据库和对 50 例 COAD 患者样本的免疫组化分析,我们证实 LONP1 表达在 COAD 中较正常组织显著升高。高 LONP1 水平与肿瘤进展、TP53 突变状态和不良预后相关。相关性分析显示,LONP1 与线粒体动力学、线粒体自噬调控因子(PINK1、AMBRA1、FUNDC1)和代谢重编程密切相关。
此外,LONP1 表达与TIL(肿瘤浸润淋巴细胞),尤其是 CD8+ T 细胞,呈正相关,提示其可能在免疫逃逸中发挥作用。免疫组化分析区分出两种模式:高 LONP1/低 TOMM20 表达与侵袭性肿瘤相关,低 LONP1/高 TOMM20 表达与更好的结局和更强的免疫浸润相关。这些发现表明,LONP1 通过线粒体调控和免疫调节促进肿瘤进展,突显其作为 COAD 预后生物标志物和治疗靶点的潜力。
LONP1, a mitochondrial ATP-dependent protease, plays a crucial role in mitochondrial homeostasis by regulating protein turnover and mitophagy. Recent studies have highlighted its upregulation in various cancers, including colorectal cancer (CRC).
This study investigates the expression of LONP1 in colon adenocarcinoma (COAD) and its correlation with mitophagy-related proteins and immune infiltration markers. Using publicly available databases and immunohistochemical analysis of 50 COAD patient samples, we confirmed that LONP1 expression is significantly elevated in COAD compared with normal tissue.
High LONP1 levels were associated with tumor progression, TP53 mutation status, and poor prognosis. Correlation analyses revealed that LONP1 is closely linked to mitochondrial dynamics, mitophagy regulators (PINK1, AMBRA1, FUNDC1), and metabolic reprogramming.
Additionally, LONP1 expression positively correlated with tumor-infiltrating lymphocytes, particularly CD8+ T cells, suggesting a potential role in immune evasion. Immunohistochemical analysis distinguished two patterns: high LONP1/low TOMM20 expression associated with aggressive tumors and low LONP1/high TOMM20 expression linked to better outcomes and stronger immune infiltration.
These findings suggest that LONP1 contributes to tumor progression through mitochondrial regulation and immune modulation, highlighting its potential as both a prognostic biomarker and a therapeutic target in COAD.
MEMBER ACCOUNT
登录成功会直接打开下一页。